Newfound Research’s Oracle ORCL Stock Holding History

Newfound Research’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1	Closed	–	–	143
2020 Q1	$0	Hold	1	–	–	﹤0.01%	162
2019 Q4	$0	Hold	1	–	–	﹤0.01%	191
2019 Q3	$0	Hold	1	–	–	﹤0.01%	200
2019 Q2	$0	Hold	1	–	–	﹤0.01%	198
2019 Q1	$0	Buy	+1	New	+$51	﹤0.01%	197

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Newfound Research's ORCL Position: Q2 2020 in Review

Newfound Research sold out of Oracle (ORCL) in Q2 2020, closing a stake of 1 share.

Newfound Research first reported a position in ORCL in Q1 2019 and held it in 5 quarters. The position peaked at $0 in Q1 2020. 1,823 funds tracked by Wall St. Rank hold ORCL as of Q2 2020.

Newfound Research reported no remaining Oracle position as of Q2 2020 after selling out during the quarter.
Newfound Research sold 1 Oracle share in Q2 2020.
Newfound Research first reported a position in Oracle in Q1 2019 and held it in 5 quarters.
Newfound Research's Oracle position peaked at $0 in Q1 2020.
1,823 funds tracked by Wall St. Rank held Oracle as of Q2 2020.

Based on Newfound Research's 13F filing for Q2 2020, filed 10 Aug 2020.